Cargando…

Chitosan-Based Nanoformulated (–)-Epigallocatechin-3-Gallate (EGCG) Modulates Human Keratinocyte-Induced Responses and Alleviates Imiquimod-Induced Murine Psoriasiform Dermatitis [Erratum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184834/ https://www.ncbi.nlm.nih.gov/pubmed/37197027 http://dx.doi.org/10.2147/IJN.S416060

Ejemplares similares

Chitosan-based nanoformulated (−)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis
por: Chamcheu, Jean Christopher, et al.
Publicado: (2018)

Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice
por: Zhang, Shuangshuang, et al.
Publicado: (2016)

Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis
por: Fenix, Kevin, et al.
Publicado: (2020)

Mechanisms and Effects of Isorhamnetin on Imiquimod-Induced Psoriasiform Dermatitis in Mice
por: Wu, Chieh-Shan, et al.
Publicado: (2022)

Complement C3 Exacerbates Imiquimod-Induced Skin Inflammation and Psoriasiform Dermatitis
por: Giacomassi, Chiara, et al.
Publicado: (2017)

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)

Tea-induced improvement of endothelial function in humans: No role for epigallocatechin gallate (EGCG)
por: Lorenz, Mario, et al.
Publicado: (2017)

Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
por: Zhong, Ying, et al.
Publicado: (2012)

Mechanism of (−)-epigallocatechin gallate (EGCG) dimerization by low-temperature plasma
por: Park, Seungil, et al.
Publicado: (2022)

Antibacterial Activity of Epigallocatechin Gallate (EGCG) against Shigella flexneri
por: Zhang, Yini, et al.
Publicado: (2023)

Characterization of the Synergistic Antioxidant Activity of Epigallocatechin Gallate (EGCG) and Kaempferol
por: Zhang, Qiang, et al.
Publicado: (2023)

Topical Treatment of Colquhounia Root Relieves Skin Inflammation and Itch in Imiquimod-Induced Psoriasiform Dermatitis in Mice
por: Li, Fei, et al.
Publicado: (2022)

Synthesis and Biological Testing of Novel Glucosylated Epigallocatechin Gallate (EGCG) Derivatives
por: Zhang, Xin, et al.
Publicado: (2016)

Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers
por: Huang, Yun-Ju, et al.
Publicado: (2020)

The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
por: Marín, Víctor, et al.
Publicado: (2023)

Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women
por: Siblini, Hiba, et al.
Publicado: (2023)

Cytoprotective Effect of Epigallocatechin Gallate (EGCG)-5′-O-α-Glucopyranoside, a Novel EGCG Derivative
por: Han, Sang Yun, et al.
Publicado: (2018)

CB2R Deficiency Exacerbates Imiquimod-Induced Psoriasiform Dermatitis and Itch Through the Neuro-Immune Pathway
por: Li, Li, et al.
Publicado: (2022)

Monoalkylated Epigallocatechin-3-gallate (C18-EGCG) as Novel Lipophilic EGCG Derivative: Characterization and Antioxidant Evaluation
por: Minnelli, Cristina, et al.
Publicado: (2020)

A novel role of HuR in ‐Epigallocatechin‐3‐gallate (EGCG) induces tumour cells apoptosis
por: Jian, Wenxuan, et al.
Publicado: (2019)

Epigallocatechin-3-Gallate (EGCG)-Inducible SMILE Inhibits STAT3-Mediated Hepcidin Gene Expression
por: Kim, Yu-Ji, et al.
Publicado: (2020)

Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
por: Mereles, Derliz, et al.
Publicado: (2011)

Epigallocatechin Gallate (EGCG) Is the Most Effective Cancer Chemopreventive Polyphenol in Green Tea
por: Du, Guang-Jian, et al.
Publicado: (2012)

Anti-Fatigue Effect of Green Tea Polyphenols (-)-Epigallocatechin-3-Gallate (EGCG)
por: Teng, Yu-song, et al.
Publicado: (2017)

Green Tea Catechin (-)-Epigallocatechin-3-Gallate (EGCG) Facilitates Fracture Healing
por: Lin, Sung-Yen, et al.
Publicado: (2020)

In Vitro Evaluation of the Antiviral Activity of the Synthetic Epigallocatechin Gallate Analog-Epigallocatechin Gallate (EGCG) Palmitate against Porcine Reproductive and Respiratory Syndrome Virus
por: Zhao, Chunjian, et al.
Publicado: (2014)

Long-Term Effects of (–)-Epigallocatechin Gallate (EGCG) on Pristane-Induced Arthritis (PIA) in Female Dark Agouti Rats
por: Leichsenring, Anna, et al.
Publicado: (2016)

The involvement of Nrf2 in the protective effects of (-)-Epigallocatechin-3-gallate (EGCG) on NaAsO(2)-induced hepatotoxicity
por: Han, Xiao-Dong, et al.
Publicado: (2017)

(−)-Epigallocatechin-3-gallate (EGCG) attenuates salt-induced hypertension and renal injury in Dahl salt-sensitive rats
por: Luo, Dan, et al.
Publicado: (2020)

Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells
por: Hazgui, Salma, et al.
Publicado: (2008)

Schedule-Dependent Effect of Epigallocatechin-3-Gallate (EGCG) with Paclitaxel on H460 Cells
por: Park, Sunghoon, et al.
Publicado: (2014)

Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG)
por: Chen, Hanyong, et al.
Publicado: (2015)

Molecular Targets of Epigallocatechin—Gallate (EGCG): A Special Focus on Signal Transduction and Cancer
por: Negri, Aide, et al.
Publicado: (2018)

Reciprocal Interactions between Epigallocatechin-3-gallate (EGCG) and Human Gut Microbiota In Vitro
por: Liu, Zhibin, et al.
Publicado: (2020)

The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review
por: Ferrari, Elena, et al.
Publicado: (2022)

Protective Effects of Epigallocatechin-3-gallate (EGCG) against the Jellyfish Nemopilema nomurai Envenoming
por: Li, Jie, et al.
Publicado: (2023)

The Potential of Epigallocatechin-3-gallate (EGCG) as Complementary Medicine for the Treatment of Inflammatory Bowel Disease
por: Schnur, Sabrina, et al.
Publicado: (2023)

Epigallocatechin gallate (EGCG) alleviates vascular dysfunction in angiotensin II-infused hypertensive mice by modulating oxidative stress and eNOS
por: Mohd Sabri, Nurul Aiza, et al.
Publicado: (2022)

The cytotoxic mechanism of epigallocatechin gallate on proliferative HaCaT keratinocytes
por: Chu, Yu-Wen, et al.
Publicado: (2017)

Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced inflammatory bone resorption, and protects against alveolar bone loss in mice
por: Tominari, Tsukasa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1npl0qh8eec07r32dnjii758j2